BFC Planning, Inc.’s Fidelity Disruptive Medicine ETF FMED Stock Holding History

BFC Planning, Inc.’s Portfolio FMED Stock Details FMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10K	Hold	350	–	–	﹤0.01%	2370
2026 Q1	$8.6K	Hold	350	–	–	﹤0.01%	2103
2025 Q4	$9.47K	Hold	350	–	–	﹤0.01%	2103
2025 Q3	$8.73K	Hold	350	–	–	﹤0.01%	1986
2025 Q2	$8.38K	Hold	350	–	–	﹤0.01%	1885
2025 Q1	$8.26K	Buy	+350	New	+$8.84K	﹤0.01%	1847

Other funds holding FMED

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Old Mission Capital Chicago, Illinois $6.31B AUM 20.77% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Parallel Advisors San Francisco, California $7.42B AUM 27.68% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return

Glen Eagle Advisors Kingston, New Jersey $793M AUM 21.06% 1-Year Est. Return

BFC Planning, Inc.'s FMED Position: Q2 2026 in Review

BFC Planning, Inc. held its Fidelity Disruptive Medicine ETF (FMED) position steady in Q2 2026 at 350 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #2370.

BFC Planning, Inc. first reported a position in FMED in Q1 2025 and has held it in 6 quarters since. 12 funds tracked by Wall St. Rank hold FMED as of Q2 2026.

BFC Planning, Inc. held 350 shares of Fidelity Disruptive Medicine ETF worth $10K as of Q2 2026.
BFC Planning, Inc. left its Fidelity Disruptive Medicine ETF share count unchanged in Q2 2026.
Fidelity Disruptive Medicine ETF made up ﹤0.01% of BFC Planning, Inc.'s portfolio in Q2 2026, its #2370 holding.
BFC Planning, Inc. first reported a position in Fidelity Disruptive Medicine ETF in Q1 2025 and has held it in 6 quarters since.
12 funds tracked by Wall St. Rank held Fidelity Disruptive Medicine ETF as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.